| |
| |
|
| Insider
Information: |
Cooper Glenn L Md |
| Relationship: |
See Remarks, Director |
| City: |
Lexington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
103,520 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$9,942,742 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
103,520 |
|
|
| Total
Value |
$9,942,742 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Repligen Corp |
RGEN |
Director |
2019-05-23 |
59,709 |
2009-11-09 |
0 |
Premium* |
|
|
Fortress Biotech, Inc. |
FBIO |
See Remarks, Director |
2012-11-30 |
43,811 |
2012-06-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RGEN |
Repligen Corp |
Director |
– • – |
2019-05-23 |
4/A |
S |
$66.91 |
$334,715 |
D/D |
(5,000) |
59,709 |
0 |
- |
|
| RGEN |
Repligen Corp |
Director |
– • – |
2019-05-23 |
4/A |
OE |
$5.00 |
$120,000 |
D/D |
24,000 |
64,709 |
0 |
- |
|
| RGEN |
Repligen Corp |
Director |
– • – |
2019-05-23 |
4 |
S |
$66.91 |
$334,715 |
D/D |
(5,000) |
35,709 |
0 |
- |
|
| RGEN |
Repligen Corp |
Director |
– • – |
2019-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
923 |
40,709 |
0 |
- |
|
| RGEN |
Repligen Corp |
Director |
– • – |
2018-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
1,486 |
39,786 |
0 |
- |
|
| RGEN |
Repligen Corp |
Director |
– • – |
2017-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,206 |
38,300 |
0 |
- |
|
| RGEN |
Repligen Corp |
Director |
– • – |
2016-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,763 |
37,094 |
0 |
- |
|
| RGEN |
Repligen Corp |
Director |
– • – |
2015-11-09 |
4 |
A |
$26.56 |
$26,564 |
D/D |
1,000 |
35,331 |
0 |
- |
|
| RGEN |
Repligen Corp |
Director |
– • – |
2015-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,019 |
34,331 |
0 |
- |
|
| RGEN |
Repligen Corp |
Director |
– • – |
2014-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,932 |
33,312 |
0 |
- |
|
| RGEN |
Repligen Corp |
Director |
– • – |
2013-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
5,342 |
31,380 |
0 |
- |
|
| FBIO |
Fortress Biotech, Inc. |
See Remarks |
• • – |
2012-11-30 |
4 |
B |
$4.02 |
$15,320 |
D/D |
3,811 |
43,811 |
2.81 |
- |
|
| RGEN |
Repligen Corp |
Director |
– • – |
2012-09-21 |
4 |
B |
$6.08 |
$60,874 |
D/D |
10,000 |
26,038 |
2.39 |
- |
|
| FBIO |
Fortress Biotech, Inc. |
See Remarks |
• • – |
2012-06-22 |
4 |
B |
$5.30 |
$52,968 |
D/D |
10,000 |
40,000 |
2.81 |
- |
|
| RGEN |
Repligen Corp |
Director |
– • – |
2012-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
11,038 |
16,038 |
0 |
- |
|
| RGEN |
Repligen Corp |
Director |
– • – |
2009-11-09 |
4 |
B |
$4.98 |
$24,900 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
